Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acid Ceramidase | 5 | 2013 | 85 | 0.780 |
Why?
|
| Prostatic Neoplasms | 5 | 2013 | 778 | 0.540 |
Why?
|
| Radiation-Sensitizing Agents | 2 | 2013 | 35 | 0.530 |
Why?
|
| Neuroimaging | 1 | 2015 | 122 | 0.460 |
Why?
|
| Sexual Behavior | 1 | 2015 | 183 | 0.460 |
Why?
|
| Propanolamines | 2 | 2013 | 70 | 0.460 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 30 | 0.450 |
Why?
|
| Amides | 1 | 2013 | 86 | 0.430 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 446 | 0.370 |
Why?
|
| Sphingolipids | 5 | 2013 | 337 | 0.280 |
Why?
|
| Brain | 1 | 2015 | 2176 | 0.240 |
Why?
|
| Antineoplastic Agents | 4 | 2013 | 1070 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 756 | 0.170 |
Why?
|
| Cell Line, Tumor | 6 | 2013 | 1851 | 0.160 |
Why?
|
| Mice, Nude | 3 | 2013 | 294 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2013 | 304 | 0.150 |
Why?
|
| Sphingosine | 3 | 2013 | 315 | 0.130 |
Why?
|
| Arousal | 1 | 2015 | 168 | 0.120 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 160 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 615 | 0.120 |
Why?
|
| Lysophospholipids | 2 | 2013 | 209 | 0.120 |
Why?
|
| Emotions | 1 | 2015 | 244 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 1 | 2013 | 89 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 71 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 61 | 0.110 |
Why?
|
| Ceramides | 3 | 2012 | 578 | 0.110 |
Why?
|
| Enzyme Induction | 1 | 2013 | 119 | 0.110 |
Why?
|
| Attention | 1 | 2015 | 225 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2013 | 155 | 0.110 |
Why?
|
| Up-Regulation | 3 | 2012 | 682 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 108 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 226 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2013 | 305 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 415 | 0.100 |
Why?
|
| Cathepsin B | 1 | 2012 | 33 | 0.100 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2012 | 65 | 0.100 |
Why?
|
| Cell Death | 1 | 2012 | 329 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 331 | 0.100 |
Why?
|
| Gene Expression | 1 | 2013 | 770 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 369 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 475 | 0.090 |
Why?
|
| Protein Binding | 1 | 2013 | 1027 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 332 | 0.080 |
Why?
|
| Mice | 4 | 2013 | 8474 | 0.080 |
Why?
|
| Mitochondria | 1 | 2012 | 643 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 659 | 0.070 |
Why?
|
| Animals | 6 | 2013 | 20881 | 0.070 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2006 | 45 | 0.070 |
Why?
|
| Desipramine | 1 | 2006 | 47 | 0.070 |
Why?
|
| Galactosylgalactosylglucosylceramidase | 1 | 2006 | 39 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 39 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2223 | 0.070 |
Why?
|
| Humans | 9 | 2015 | 68618 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 561 | 0.060 |
Why?
|
| Male | 6 | 2013 | 37321 | 0.050 |
Why?
|
| Neoplasms | 1 | 2013 | 1667 | 0.050 |
Why?
|
| Apoptosis | 2 | 2013 | 1641 | 0.030 |
Why?
|
| Karyopherins | 1 | 2013 | 11 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2013 | 55 | 0.030 |
Why?
|
| Taxoids | 1 | 2013 | 41 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 160 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 66 | 0.030 |
Why?
|
| Carbocyanines | 1 | 2012 | 13 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2012 | 75 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 81 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2012 | 66 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 223 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2012 | 77 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2012 | 83 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2012 | 93 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2013 | 312 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 381 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2012 | 128 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 258 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 332 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2012 | 525 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 954 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 306 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 630 | 0.020 |
Why?
|
| Myristates | 1 | 2008 | 21 | 0.020 |
Why?
|
| Prostate | 1 | 2009 | 116 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2008 | 140 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 201 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 791 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 434 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2006 | 144 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 710 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1753 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 2689 | 0.010 |
Why?
|
| Female | 1 | 2012 | 38074 | 0.010 |
Why?
|